Lymphocytes Subsets in the Course of Continuous Ambulatory Peritoneal Dialysis (CAPD)

Figures & data

Table 1. Monoclonal Antibodies Used for Lymphocyte Analysis

Cluster differentiation	Specificity
CD2 +	T lymphocytes, thymocytes
CD3 +	Mature T cells
CD3 +/4 +	T helper cells
CD3 +/8 +	T suppressor/cytotoxic cells
CD19	B lymphocytes
CD3 −/16 + 56 +	NK cells

Table 2. Immunophenotypes of Patients on CAPD

Groups	N	(WBC)	(LYM)	(CD2)	(CD3)	(CD3/4)	(CD3/8)	(CD19)	NK	NK like	CD4/CD8
1	6	8995 ± 2478	22.68 ± 4.99	81.5 ± 4.5	72.75 ± 7.33	40.8 ± 6.4	29.2 ± 8.6	9.95 ± 4.55	11.75 ± 6.1	2.7 ± 1.8	1.56 ± 0.75
2	6	6950 ± 1427	21.6 ± 6.13	84.15 ± 7.7	68.8 ± 15	38.7 ± 4.5	26 ± 11.8	6.3 ± 4.16	15.4 ± 8.4	1.9 ± 1.33	1.7 ± 0.6
3	16	8214 ± 2625	24.1 ± 11.24	84.12 ± 5.4	65.6 ± 19.9	43.2 ± 9.9	21.7 ± 9.3	6.9 ± 4.3	16.7 ± 11.3	2.9 ± 2.14	2.46 ± 1.6
4	9	9208 ± 2309	21.77 ± 6.88	84.97 ± 4.96	70.6 ± 9.9	39 ± 5.8	24 ± 8.9	6.43 ± 4.47	14.8 ± 9.13	2.7 ± 1.9	2.15 ± 1.42
Total	37	8377 ± 2404	22.9 ± 8.55	83.9 ± 5.5	68.0 ± 15.35	41 ± 7.8	24.2 ± 9.5	7.2 ± 4.35	15.22 ± 9.5	2.7 ± 1.9	2.11 ± 1.42
Control	45	7151 ± 1387	31.75 ± 7.3	80.15 ± 4.66	73.7 ± 5.8	45.2 ± 6.65	24.35 ± 6.44	12.3 ± 3.44	10.13 ± 4.1	3.14 ± 2.54	2.0 ± 0.72